Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in plasma/serum and urine of women during term and threatened preterm labor: A clinical approach

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 14, Issue 3, 2003, Pages 170-176

  Makrakis, E ^a,b   Grigoriou, O ^a   Kouskouni, E ^a   Vitoratos, N ^a   Salamalekis, E ^a   Chatzoudi, E ^a   Creatsas, G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Labor; Matrix metalloproteinases; MMP 9; Premature rupture of membranes; Preterm labor; TIMP 1

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; LABOR; NORMAL HUMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UTERUS CONTRACTION;

EID: 0141762420     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.14.3.170.176     Document Type: Article

References (24)

1. Rawlings ND, Barrett AJ. Evolutionary families of metalopeptidases. Methods Enzymol 1995;248:183-228
2. Sang QA, Douglas AD. Computational sequence analysis of matrix metalloproteinases. J Protein Chem 1996;15:137-60
3. Nagase H, Barrett AJ, Woessner JF. Nomenclature and glossary of the matrix metalloproteinases. Matrix Suppl 1992; 1:421-4
4. Desrochers PE, Mookhtiar K, Van Wart HE, et al. Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J Biol Chem 1992;267:5005-12
5. Wilhelm SM, Collier IE, Marmer BL, et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989;264:17213-21
6. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinases activity with potential applicability to the entire matrix metalloproteinases gene family. Proc Natl Acad Sci USA 1990;87:5578-82
7. Douglas DA, Shi YE, Sang QA. Computational sequence analysis of the tissue inhibitor of metalloproteinases family. J Protein Chem 1997;16:237-55
8. Ward RV, Hembry RM, Reynolds JJ, et al. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J 1991; 278:179-87
9. Rechberger T, Uldbjerg N, Oxlund H. Connective tissue changes in the cervix during normal pregnancy and pregnancy complicated by cervical incompetence. Obstet Gynecol 1988;71:563-7
10. Dieron D, Bryant-Greenwood GD. Collagens, collagenolytic enzymes and inhibitors in the human fetal membranes and residua. Trophoblast Res 1991;5:205-16
11. McGregor JA, French JI. Preterm birth: the role of infection and inflammation. Medscape Wom Health 1997;2:1
12. Gomez R, Ghezzi F, Romero R. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995;22:281-342
13. Rath W, Winkler M, Kemb B. The importance of extracellular matrix in the induction of preterm delivery. J Perinat Med 1998;26:437-41
14. Fortunato SJ, Menon R, Bryant C, et al. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes. Am J Obstet Gynecol 2000;182:1468-76
15. Fortunato SJ, Menon R. Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. Am J Obstet Gynecol 2001;184:1399-405
16. Winkler M, Oberpichler A, Tschesche H, et al. Collagenolysis in the lower uterine segment during parturition at term correlations with stage of cervical dilatation and duration of labor. Am J Obstet Gynecol 1999;181:153-8
17. Bryant-Greenwood GD, Yamamoto SY. Control of peripartal collagenolysis in the human chorion-decidua. Am J Obstet Gynecol 1995;172:63-70
18. McLaren J, Taylor DJ, Bell SC. Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture. Am J Obstet Gynecol 2000;182: 409-16
19. Maymon E, Romero R, Pacora P, et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 2000;183:887-94
20. Athayde N, Romero R, Gomez R, et al. Matrix metalloproteinases-9 in preterm and term human parturition. J Matern Fetal Med 1999;8:213-19
21. Fortunato SJ, Menon R, Lombardi SJ. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Med 1999; 27:362-8
22. Athayde N, Edwin SS, Romero R, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1998;179:1248-53
23. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinase-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996;174:1371-6
24. Agrez M, Gu X, Giles W. Matrix metalloproteinase 9 activity in urine of patients at risk for premature delivery. Am J Obstet Gynecol 1999;181:387-8